Filing Details
- Accession Number:
- 0001179110-18-006817
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-15 18:15:41
- Reporting Period:
- 2018-05-11
- Accepted Time:
- 2018-05-15 18:15:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1005201 | Depomed Inc | DEPO | Pharmaceutical Preparations (2834) | 943229046 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1367754 | M Matthew Gosling | C/O Depomed, Inc. 7999 Gateway Boulevard, Suite 300 Newark CA 94560 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-05-11 | 19,674 | $7.07 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sold, in part, in accordance with divorce agreement.
- This price represents the average selling price (within a range of $7.01-$7.16) of the shares of common stock of Depomed, Inc. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares at each price within the range set forth in this footnote.
Billionaire Hedge Funds
